1 (Translation) MD. 063/2018 May 9 , 2018 Re: Management Discussion and Analysis For the Operating Results ended March 31, 2018 To: President The Stock Exchange of Thailand Management Discussion and
President The Stock Exchange of Thailand Rajthanee Hospital Public Company Limited (“the Company”) would like to clarify the operating results of the Company and its subsidiaries for the 2nd quarter of 2018
Page 1 of 4 No. RJH – SET 10/2018 12 November 2018 Subject : Management Discussion and Analysis for the 3rd quarter of 2018 ending September 30, 2018 To : The President The Stock Exchange of Thailand
IDH-AC-000-อส6305/04.00 11 May 2020 Re: Management Discussion and Analysis Operating results for the three-month period ended 31 March 2020 To: President The Stock Exchange of Thailand Overview of
No. ADD 18/2024 9 August 2024 Subject: Management discussion and analysis for the performance for the six-month period ended 30 June 2024 To: President The Stock Exchange of Thailand AddTech Hub
, The Stock Exchange of Thailand With respect to the financial statements for the year ended 31 December 2019, as submitted by the Company, which has been audited by the external auditor, considered by
Page 1 of 4 No. RJH – SET 3/2020 24 February 2020 Subject : Management’s Discussion and Analysis for the 4th Quarter of 2019 To : The President The Stock Exchange of Thailand Rajthanee Hospital
26 February 2020 Subject : Management Discussion and Analysis for 2019 To : Director and the President, The stock Exchange of Thailand Yggdrazil Group Public Company Limited (“Company”) would like to
Stock Exchange of Thailand The Company wishes to present the Management Discussion & Analysis (MD&A) on the operating and financial status for the year 2017. The MD&A would enable the investors to better
. DOD017/2562 May 8, 2019 Re: Management’s Discussion and Analysis (MD&A) of the Consolidated Financial Results for Quarter 1 of 2019 To: The President The Stock Exchange of Thailand DOD Biotech Public